Fora Capital, LLC Celldex Therapeutics, Inc. Transaction History

Fora Capital, LLC

  • $789 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 08, 2023
BUY
$27.78 - $45.38 $197,654 - $322,878
7,115 New
7,115 $317,000
Q3 2021

Nov 15, 2021
SELL
$28.95 - $55.99 $285,475 - $552,117
-9,861 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$20.71 - $35.37 $204,221 - $348,783
9,861 New
9,861 $330 Million

Others Institutions Holding CLDX

# of Institutions
207
Shares Held
67.3M
Call Options Held
1.69M
Put Options Held
980K
View Full List

About Celldex Therapeutics, Inc.

CLDX Quotes by TradingView
  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $1.23B
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track This Portfolio

Track Fora Capital, LLC Portfolio

Follow Fora Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fora Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email